other material
confidence high
sentiment negative
materiality 0.70
Galera Therapeutics converts all Series B Preferred Stock into 42.8M common shares
Galera Therapeutics, Inc.
- Converted 42,839.11 Series B preferred shares into 42,839,103 common shares on May 15, 2026.
- No fractional shares were issued; holders will receive cash in lieu of fractional shares.
- After conversion, no shares of Series B Preferred Stock remain outstanding.